Sealants, glues, hemostats not poised for world domination

Market shares for sales of sealants, glues, and hemostats vary considerably from region to region globally due to the significant variations in the local market demand, rate of adoption of specific manufacturers’ products, the regulatory climate, local economies, and other factors. Consequently, manufacturers with significant share of sales in the U.S. or Europe or Asia/Pacific may have considerably lower or higher shares in other regions.

In the U.S., Ethicon and Baxter have dominant positions in sales of surgical sealants. However, in Europe and Asia/Pacific, Baxter has substantially smaller position, particularly relative to competitors like Takeda Pharmaceuticals and The Medicines Company.

Source: Report #S290, MedMarket Diligence, LLC

In the market for hemostats, similarly, Ethicon and Baxter have dominant position in the U.S. market, but in Asia/Pacific and Europe, Baxter is subordinate to Takeda Pharmaceuticals, CryoLife, and others.

Source: Report #S290, MedMarket Diligence, LLC

In medical glues, CryoLife has risen to the fore with its BioGlue, such that it has a global leading position as well as specifically in the U.S., Europe, and Asia/Pacific.

Source: Report #S290, MedMarket Diligence, LLC

Leave a Reply

Your email address will not be published. Required fields are marked *